Tag: SakuraStar

Sustained long-term efficacy and safety of satralizumab in NMOSD

Presented By
Prof. Jeffrey Bennett, University of Colorado Hospital, CO, USA
Trial
Phase 3, SAkuraSky; SAkuraStar
Conference
AAN 2022
Type
Peer-reviewed article

2 June 2022 15:29

Eculizumab, satralizumab, or inebilizumab for NMOSD?

Presented By
Prof. Dean Wingerchuk, Mayo Clinic Phoenix/Scottsdale, AZ, USA
Trial
Phase 3, N-MOmentum, PREVENT, SAkuraStar, SAkuraSky
Conference
ECTRIMS 2021
Type
Peer-reviewed article

9 December 2021 15:37

Long-term efficacy of satralizumab for NMOSD

Presented By
Dr Ingo Kleiter, Ruhr-Universität Bochum, Germany
Trial
Phase 3, SAkuraStar, SAkuraSky
Conference
ECTRIMS 2021
Type
Peer-reviewed article

9 December 2021 15:34

ECTRIMS 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Trial
COMBAT-MS, SAkuraSky, SAkuraStar, ULTIMATE I and II, ORATORIO
Conference
ECTRIMS 2021

1 November 2021 08:32

Satralizumab efficacious in AQP4-IgG-positive patients with NMOSD

Trial
Phase 3, SAkuraSky, SAkuraStar
Conference
EAN 2021
Type
Peer-reviewed article

18 August 2021 10:30

Satralizumab lowers risk of severe relapse in NMOSD patients

Trial
SAkuraSky, SAkuraStar
Conference
MS Virtual 2020
Type
Peer-reviewed article

25 November 2020 16:45

Long-term safety of satralizumab consistent with double-blind periods

Presented By
Prof. Benjamin Greenberg, University of Texas Southwestern Medical Center, USA
Trial
Phase 3, SAkuraSky; SAkuraStar
Conference
EAN 2020
Type
Peer-reviewed article

10 September 2020 13:58

Targeted therapies for NMOSD in development

Presented By
Dr Dean Wingerchuk, Mayo Clinic, Rochester, United States
Trial
Phase 3, PREVENT
Conference
ECTRIMS 2019
Type
Peer-reviewed article

8 November 2019 11:17
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com